Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2.
Schleicher EM, Gairing SJ, Castven D, Hock CS, Dobbermann H, Heinrich S, Meineck M, Kaps L, Galle PR, Weinmann-Menke J, Nguyen-Tat M, Marquardt JU, Labenz C.
Schleicher EM, et al. Among authors: marquardt ju.
Am J Physiol Gastrointest Liver Physiol. 2024 May 1;326(5):G583-G590. doi: 10.1152/ajpgi.00304.2023. Epub 2024 Mar 19.
Am J Physiol Gastrointest Liver Physiol. 2024.
PMID: 38502914